Supreme Court Agrees To Take Up Case On Product Warnings Related To Osteoporosis Drug
The pharmaceutical industry has argued that once the Food and Drug Administration approves product labeling, a drugmaker cannot be sued in state court for failing to warn about risks.
Stat:
Supreme Court To Review Merck Case With Implications For Consumers
The U.S. Supreme Court has agreed to review a case that has significant implications for consumers and drug makers concerning lawsuits that are filed over product warnings. The case involves hundreds of lawsuits that were filed by women who claim they suffered bone fractures after taking Fosamax, a Merck (MRK) drug used to combat osteoporosis. Last year, a federal appeals court overturned a lower court and decided the lawsuits should proceed, and last month, the U.S. Solicitor General urged the Supreme Court to review the matter. (Silverman, 6/28)
In other news from the court —
The Associated Press:
US Supreme Court Declines City’s Bid On Abortion-Notice Law
The U.S. Supreme Court has declined to hear from a Maryland city that wants pregnancy centers opposed to abortion to notify patients they don’t provide such services. The Daily Record of Baltimore reports the high court declined Thursday to hear Baltimore’s appeal of a lower-court ruling that struck down a city ordinance requiring notification. (6/28)
